Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-23

FDA Approved: OXALIPLATIN — Original Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved a generic Oxaliplatin injectable from Gland Pharma Limited under ANDA207385 for use in colorectal cancer. This approval makes a generic oxaliplatin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

ORIG AP for OXALIPLATIN (OXALIPLATIN)